FdaApplication
NDA 211225
Identifiers
- fda_app_no: NDA211225
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2019-03-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZYKADIA | CERITINIB | 150MG | TABLET;ORAL |
1 product